email article
In recognition of the 50th anniversary of the National Cancer Act, retiring chief medical officer Richard Schilsky, MD, of the American Society of Clinical Oncology (ASCO), reviews progress and major advances in cancer that have occurred since 1971.
A year after posting a negative trial in metastatic bladder cancer, AstraZeneca has voluntarily withdrawn the indication for durvalumab (Imfinzi) in the U.S. after consultation with the FDA. (
Endpoints News)
ASCO and Cancer Care Ontario published updated guidance for treating metastatic non-small cell lung cancer (NSCLC) associated with targetable mutations.
Sanofi and Regeneron announced FDA approval of cemiplimab (Libtayo) for first-line treatment of metastatic NSCLC with PD-L1 expression ≥50%.
Read the responses from the entities included in the Power Gap theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
Challenge aimed at improving patient outcomes by identifying solutions to reduce time between diagnosis and treatment for lung cancer patients Merck Canada and MaRS Discovery District are proud to launch the Lung Cancer Innovation Challenge . The competition challenges Ontario -based innovators to identify, implement and scale solutions that can enhance an Ontario lung cancer patient’s journey by seeking to reduce … Challenge aimed at improving patient outcomes by identifying solutions to reduce time between diagnosis and treatment for lung cancer patients
Merck Canada and MaRS Discovery District (MaRS) are proud to launch the Lung Cancer Innovation Challenge . The competition challenges Ontario -based innovators to identify, implement and scale solutions that can enhance an Ontario lung cancer patient’s journey by seeking to reduce the length of time between diagnosis and treatment for lung cancer pa
Cancer screening coach isn t seeing patients because of the pandemic
The region s mobile cancer screening coach usually provides services to people experiencing barriers to health-care. But shutdowns and rising COVID-19 cases are keeping it off the road.
Social Sharing